Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Multicenter Phase 1 Study of E7046 in Subjects With Selected Advanced Malignancies

NCT02540291 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT02540291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02540291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Multicenter Phase 1 Study of E7046 in Subjects With Selected Advanced Malignancies
Lead sponsor
Eisai Inc.
Phase
Phase 1
Overall status
Terminated
Start date
July 30, 2015
Completion date
February 27, 2018
Enrollment
31 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

tumors